The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors.

ABSTRACT:

Purpose

To develop a multidisciplinary consensus for high quality multidisciplinary implementation of brachytherapy using Yttrium-90 (⁹⁰Y) microspheres transarterial radioembolization (⁹⁰Y TARE) for primary and metastatic cancers in the liver.

Methods and materials

Members of the American Brachytherapy Society (ABS) and colleagues with multidisciplinary expertise in liver tumor therapy formulated guidelines for ⁹⁰Y TARE for unresectable primary liver malignancies and unresectable metastatic cancer to the liver. The consensus is provided on the most recent literature and clinical experience.

Results

The ABS strongly recommends the use of ⁹⁰Y microsphere brachytherapy for the definitive/palliative treatment of unresectable liv

SUBMITTER: Sharma NK 

PROVIDER: S-EPMC10868645 | biostudies-literature | 2022 Sep-Oct

REPOSITORIES: biostudies-literature